|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 11491 |
FusionGeneSummary for ELOVL5_GLO1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ELOVL5_GLO1 | Fusion gene ID: 11491 | Hgene | Tgene | Gene symbol | ELOVL5 | GLO1 | Gene ID | 60481 | 2739 |
| Gene name | ELOVL fatty acid elongase 5 | glyoxalase I | |
| Synonyms | HELO1|SCA38|dJ483K16.1 | GLOD1|GLYI|HEL-S-74 | |
| Cytomap | 6p12.1 | 6p21.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | elongation of very long chain fatty acids protein 53-keto acyl-CoA synthase ELOVL5ELOVL FA elongase 5ELOVL family member 5, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)fatty acid elongase 1homolog of yeast long chain polyun | lactoylglutathione lyaseS-D-lactoylglutathione methylglyoxal lyasealdoketomutaseepididymis secretory protein Li 74glx Iglyoxalase domain containing 1ketone-aldehyde mutaselactoyl glutathione lyasemethylglyoxalase | |
| Modification date | 20180523 | 20180527 | |
| UniProtAcc | Q9NYP7 | Q04760 | |
| Ensembl transtripts involved in fusion gene | ENST00000370918, ENST00000304434, ENST00000542638, ENST00000541407, ENST00000486973, ENST00000370913, | ENST00000373365, ENST00000470973, | |
| Fusion gene scores | * DoF score | 7 X 3 X 7=147 | 3 X 3 X 3=27 |
| # samples | 8 | 4 | |
| ** MAII score | log2(8/147*10)=-0.877744249949002 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/27*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ELOVL5 [Title/Abstract] AND GLO1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ELOVL5 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 20427700 |
| Hgene | ELOVL5 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 20427700|20937905 |
| Hgene | ELOVL5 | GO:0042761 | very long-chain fatty acid biosynthetic process | 20427700|20937905 |
| Tgene | GLO1 | GO:0043066 | negative regulation of apoptotic process | 11489834 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | OV | TCGA-25-1318-01A | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000370918 | ENST00000373365 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-intron | ENST00000370918 | ENST00000470973 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-3CDS | ENST00000304434 | ENST00000373365 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-intron | ENST00000304434 | ENST00000470973 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| intron-3CDS | ENST00000542638 | ENST00000373365 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| intron-intron | ENST00000542638 | ENST00000470973 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-3CDS | ENST00000541407 | ENST00000373365 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-intron | ENST00000541407 | ENST00000470973 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-3CDS | ENST00000486973 | ENST00000373365 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-intron | ENST00000486973 | ENST00000470973 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-3CDS | ENST00000370913 | ENST00000373365 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
| 5UTR-intron | ENST00000370913 | ENST00000470973 | ELOVL5 | chr6 | 53213615 | - | GLO1 | chr6 | 38654750 | - |
Top |
FusionProtFeatures for ELOVL5_GLO1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ELOVL5 | GLO1 |
| Catalyzes the conversion of hemimercaptal, formed frommethylglyoxal and glutathione, to S-lactoylglutathione. Involvedin the regulation of TNF-induced transcriptional activity of NF-kappa-B. Required for normal osteoclastogenesis.{ECO:0000269|PubMed:19199007, ECO:0000269|PubMed:23122816,ECO:0000269|PubMed:9705294}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ELOVL5_GLO1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ELOVL5_GLO1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ELOVL5 | ELAVL1, CERS2, YIPF5, SUCO, DPEP1, APLNR, SLC7A1, SLC22A9, UBC, TIMM17A, ROMO1 | GLO1 | CPLX1, IGBP1, PNP, AGL, ITPA, IKBKG, MAP3K13, ASB12, MEOX2, CUL7, ACY1, AKR1B1, AKR1B15, ATIC, FABP5, ALDOA, ALDOC, GMPS, HSPB1, PGAM1, PRDX6, PREP, UMPS, GLOD4, GRHPR, HNRNPA1, HSD17B14, HSPE1, IMPA2, PGM3, PGP, PPA1, PSMG4, QDPR, STIP1, TKT, EWSR1, FOS, CDC25C, EYA4, SOD1, TRIM25 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ELOVL5_GLO1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | GLO1 | Q04760 | DB00328 | Indomethacin | Lactoylglutathione lyase | small molecule | approved|investigational |
| Tgene | GLO1 | Q04760 | DB00143 | Glutathione | Lactoylglutathione lyase | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for ELOVL5_GLO1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ELOVL5 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | ELOVL5 | C0036341 | Schizophrenia | 1 | PSYGENET |
| Hgene | ELOVL5 | C4014812 | SPINOCEREBELLAR ATAXIA 38 | 1 | ORPHANET;UNIPROT |
| Tgene | GLO1 | C0011570 | Mental Depression | 2 | PSYGENET |
| Tgene | GLO1 | C0011581 | Depressive disorder | 2 | CTD_human;PSYGENET |
| Tgene | GLO1 | C0003469 | Anxiety Disorders | 1 | CTD_human |
| Tgene | GLO1 | C0004352 | Autistic Disorder | 1 | CTD_human |
| Tgene | GLO1 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| Tgene | GLO1 | C0025202 | melanoma | 1 | CTD_human |
| Tgene | GLO1 | C0036341 | Schizophrenia | 1 | PSYGENET |
| Tgene | GLO1 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|